News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
522,823 Results
Type
Article (16732)
Company Profile (158)
Press Release (505927)
Multimedia
Podcasts (84)
Webinars (14)
Section
Business (180869)
Career Advice (786)
Deals (28551)
Drug Delivery (96)
Drug Development (58943)
Employer Resources (52)
FDA (10784)
Job Trends (9626)
News (259776)
Policy (20509)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (612)
Accelerated approval (30)
ADA (27)
Adcomms (21)
Allergies (110)
Alliances (36648)
ALS (121)
Alzheimer's disease (1181)
Antibody-drug conjugate (ADC) (347)
Approvals (11242)
Artificial intelligence (450)
ASCO (201)
Autoimmune disease (237)
Automation (35)
Bankruptcy (301)
Best Places to Work (7345)
BIO (52)
BIOSECURE Act (10)
Biosimilars (164)
Biotechnology (97)
Bladder cancer (153)
Brain cancer (36)
Breast cancer (554)
Cancer (4204)
Cardiovascular disease (330)
Career advice (645)
Career pathing (25)
CAR-T (207)
CDC (13)
Celiac Disease (1)
Cell therapy (574)
Cervical cancer (37)
Clinical research (52698)
Collaboration (1531)
Company closure (1)
Compensation (1425)
Complete response letters (64)
COVID-19 (1049)
CRISPR (69)
C-suite (887)
Cystic fibrosis (88)
Data (5950)
Decentralized trials (1)
Denatured (15)
Depression (130)
Dermatology (74)
Diabetes (432)
Diagnostics (4399)
Digital health (44)
Diversity (8)
Diversity, equity & inclusion (13)
Drug discovery (227)
Drug pricing (171)
Drug shortages (26)
Duchenne muscular dystrophy (199)
Earnings (76037)
Editorial (47)
Employer branding (7)
Employer resources (57)
Events (92462)
Executive appointments (803)
FDA (13534)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (25)
Funding (1128)
Gene editing (150)
Generative AI (42)
Gene therapy (419)
GLP-1 (692)
Government (1631)
Grass and pollen (3)
Guidances (300)
Healthcare (10061)
Hematology (108)
HIV (65)
Huntington's disease (36)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (75)
Immunology and inflammation (237)
Immuno-oncology (84)
Indications (158)
Infectious disease (1302)
Inflammatory bowel disease (150)
Inflation Reduction Act (8)
Influenza (92)
Intellectual property (259)
Interviews (109)
IPO (13284)
IRA (42)
Job creations (2516)
Job search strategy (567)
JPM (40)
Kidney cancer (16)
Labor market (76)
Layoffs (275)
Leadership (30)
Legal (5810)
Liver cancer (56)
Longevity (18)
Lung cancer (583)
Lymphoma (303)
Machine learning (35)
Management (23)
Manufacturing (803)
Marketing (6)
MASH (155)
Medical device (8802)
Medtech (8924)
Mergers & acquisitions (16318)
Metabolic disorders (1176)
mRNA (104)
Multiple sclerosis (131)
NASH (12)
Neurodegenerative disease (299)
Neuropsychiatric disorders (77)
Neuroscience (2262)
Neurotech (1)
NextGen: Class of 2026 (3541)
Non-profit (937)
Now hiring (46)
Obesity (579)
Opinion (174)
Ovarian cancer (166)
Pain (211)
Pancreatic cancer (219)
Parkinson's disease (240)
Partnered (21)
Patents (531)
Patient recruitment (520)
Peanut (34)
People (45104)
Pharmaceutical (39)
Pharmacy benefit managers (28)
Phase 1 (16760)
Phase 2 (23594)
Phase 3 (16508)
Pipeline (7339)
Policy (205)
Postmarket research (1681)
Preclinical (6955)
Press Release (35)
Prostate cancer (214)
Psychedelics (26)
Radiopharmaceuticals (240)
Rare diseases (753)
Real estate (3617)
Recruiting (26)
Regulatory (16745)
Reports (28)
Research institute (731)
Resumes & cover letters (133)
Rett syndrome (39)
RNA editing (14)
RSV (72)
Schizophrenia (152)
Series A (192)
Series B (147)
Service/supplier (6)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (107)
Sponsored (13)
Startups (2461)
Stomach cancer (12)
Supply chain (90)
Tariffs (93)
The Weekly (67)
Vaccines (465)
Venture capital (95)
Weight loss (380)
Women's health (88)
Worklife (8)
Date
Today (67)
Last 7 days (309)
Last 30 days (1342)
Last 365 days (21848)
2026 (12214)
2025 (21887)
2024 (25584)
2023 (28947)
2022 (37568)
2021 (39922)
2020 (36025)
2019 (25993)
2018 (19664)
2017 (21672)
2016 (20565)
2015 (26355)
2014 (23125)
2013 (19446)
2012 (21494)
2011 (21755)
2010 (21271)
Location
Africa (374)
Alabama (70)
Alaska (2)
Arizona (302)
Arkansas (11)
Asia (23469)
Australia (2678)
California (11805)
Canada (3189)
China (767)
Colorado (491)
Connecticut (428)
Delaware (228)
Europe (40338)
Florida (1804)
Georgia (368)
Hawaii (2)
Idaho (46)
Illinois (724)
India (74)
Indiana (356)
Iowa (15)
Japan (490)
Kansas (101)
Kentucky (31)
Louisiana (26)
Maine (25)
Maryland (1240)
Massachusetts (7956)
Michigan (307)
Minnesota (544)
Mississippi (5)
Missouri (78)
Montana (20)
Nebraska (14)
Nevada (114)
New Hampshire (62)
New Jersey (2769)
New Mexico (25)
New York (2905)
North Carolina (1322)
North Dakota (4)
Northern California (5850)
Ohio (310)
Oklahoma (15)
Oregon (18)
Pennsylvania (2256)
Puerto Rico (28)
Rhode Island (32)
South America (561)
South Carolina (75)
South Dakota (1)
Southern California (4893)
Tennessee (124)
Texas (1874)
United States (39084)
Utah (357)
Vermont (1)
Virginia (160)
Washington D.C. (51)
Washington State (928)
West Virginia (2)
Wisconsin (79)
Wyoming (1)
522,823 Results for "cmp pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
CMP Pharma, Inc Announces that Atorvaliq®, the First and Only FDA-approved Liquid Suspension of Atorvastatin is Now Available
CMP Pharma, Inc. announced today that Atorvaliq (atorvastatin calcium) Oral Suspension, 20 mg/5 mL, the first and only FDA-approved oral liquid of atorvastatin, is now available.
June 23, 2023
·
4 min read
Bio NC
CMP Pharma, Inc Announces that Liqrev®, the First and Only Ready-made FDA-approved Liquid Suspension of Sildenafil is Now Available
CMP Pharma, Inc. announced today that Liqrev (Sildenafil) Oral Suspension, 10 mg/mL, the first and only FDA-approved ready-made oral liquid of sildenafil, is now available.
June 21, 2023
·
5 min read
Bio NC
CMP Pharma, Inc Announces that Tadliq®, the First and Only FDA-approved Liquid Suspension of Tadalafil, is Now Available
CMP Pharma announced today that Tadliq ® (Tadalafil) Oral Suspension, 20 mg/5 mL, the first and only FDA-approved oral liquid suspension of tadalafil, is now available.
October 24, 2022
·
3 min read
Bio NC
CMP Pharma, Inc Announces that Norliqva®, the First and Only FDA-approved Liquid Solution of Amlodipine, is Now Available
CMP Pharma announced today that Norliqva® (Amlodipine) Oral Solution, 1 mg/mL, the first and only FDA-approved oral liquid solution of the besylate salt of amlodipine, a long-acting calcium channel blocker, is now available.
June 1, 2022
·
4 min read
Bio NC
CMP Pharma, Inc. Announces Unit Dose Packaging for CaroSpir®, The First and Only FDA-Approved Spironolactone Oral Suspension
CMP Pharma today announced that CaroSpir (Spironolactone Oral Suspension, 25 mg/5 mL), the first and only FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone, is now available in a unit dose cup.
October 18, 2021
·
4 min read
FDA
First FDA approved Potassium Phosphates Injection from CMP Pharma Has Been Approved.
CMP Pharma, Inc. announced today that its Potassium Phosphates Injection, the first ever FDA approved injection.
February 27, 2020
·
4 min read
Bio NC
CMP Pharma’s Potassium Phosphates Injection Receives FDA Shelf Life Extension for Specific Lots
CMP Pharma announced today that in order to mitigate drug shortage concerns, the FDA’s CDER Office of Compliance has granted a shelf life extension for CMP Development LLC Potassium Phosphates Injection (NDA 212121).
March 31, 2023
·
4 min read
Press Releases
CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
May 14, 2026
·
8 min read
Business
Deep dive: Pharma CEO compensation report
Who is the highest paid CEO in all of pharma? In this special edition,
BioSpace
examines top paid CEOs and their pay packages.
June 30, 2026
·
1 min read
·
Annalee Armstrong
Bio NC
First FDA approved Potassium Phosphates Injection from CMP Pharma Is Now Available
First FDA Approved Potassium Phosphates Injection Expected to Address Previous Market Shortages and Provide Improved Safety Profile as Opposed to Using Unapproved Products
March 17, 2020
·
4 min read
1 of 52,283
Next
